Yuki Himoto1
1Department of Diagnostic Imaging and Nuclear Medicine, Kyoto Univesity Hospital, Kyoto, Japan
Synopsis
Keywords: Body: Urogenital
Motivation: Conventional MRI is crucial for uterine cancer in clinical settings. Radiomics, utilizing quantitative imaging features, has rapidly evolved in research. A brief review provides insights for addressing current clinical challenges and guiding future developments.
Goal(s): The goals are to grasp the roles of conventional MRI, achievements in radiomic studies for uterine cancer (particularly endometrial cancer), and the limitations and improvements in imaging quality.
Approach: Reviewing the latest research on MRI and radiomics in uterine cancer, with a primary focus on endometrial cancer.
Results: Despite limitations, radiomics continues to advance. Improvements in conventional MRI quality for gynecologic imaging are clinically significant and enhance radiomics.
Impact: Grasping current improvements in MRI quality and radiomics,
along with identifying challenges, offers insights for addressing clinically
relevant issues in uterine cancer.
In endometrial and cervical cancer, MRI is primarily used for
accurate staging, with T2-weighted imaging (T2WI) as a key sequence [1]. Over the
past decade, diffusion-weighted imaging (DWI) has become widely accepted in
routine clinical practice. Recently, radiomics has gained attention in cancer
research, including gynecological cancers. In the context of endometrial
cancer, models focusing on lymphovascular invasion (LVI), deep myometrial
invasion, and lymph node metastasis have been major research subjects [2]. In cervical cancer, the main focuses have been on lymph node
metastasis and treatment response to chemoradiation. Radiomics might prove most
effective in addressing clinically relevant issues where current imaging
diagnostics struggle, such as predicting LVI, lymph node metastasis, or
treatment response.
Commonly
cited drawbacks of radiomics include issues related to generalizability and
reproducibility. While clinical implementation may take time, steady progress
is being made in overcoming these challenges [2, 3]. In considering MRI radiomics in uterine cancer, vulnerability
to artifacts is identified as a specific issue: motion artifacts from
respiratory movements or intestines; susceptibility artifacts by rectal air
often affecting DWI and its apparent diffusion coefficient (ADC) map. Motion
artifacts by intestines is particularly noteworthy when performed without the
administration of antispasmodics. Improving the robustness of T2WI and DWI to
artifact is essential to ensure the generalizability of radiomics.
Several
promising techniques have been reported for improving image quality. As a
representative, deep learning (DL) reconstruction is gaining attention [4]. DL reconstruction enhances spatial resolution, reduces noise,
and shortens acquisition time. The reduction of acquisition time, while
maintaining image quality, directly leads to artifact resistance. Obtaining
high-quality T2WI and DWI, even without antispasmodics, not only improves
conventional imaging diagnostics but also benefits image analysis techniques,
including radiomics. Furthermore, exploration of user-friendly clinical tools
based on advanced computation techniques is crucial in future imaging diagnostics,
extending beyond radiomics.Acknowledgements
No acknowledgement found.References
1. Kido, A., et al., Preoperative Imaging Evaluation of
Endometrial Cancer in FIGO 2023. J Magn Reson Imaging, 2023.
2. Lefebvre, T.L.,
et al., Development and Validation of
Multiparametric MRI-based Radiomics Models for Preoperative Risk Stratification
of Endometrial Cancer. Radiology, 2022. 305(2): p. 375-386.
3. Zwanenburg, A.,
et al., The Image Biomarker
Standardization Initiative: Standardized Quantitative Radiomics for
High-Throughput Image-based Phenotyping. Radiology, 2020. 295(2): p. 328-338.
4. Tsuboyama, T., et
al., Impact of Deep Learning
Reconstruction Combined With a Sharpening Filter on Single-Shot Fast Spin-Echo
T2-Weighted Magnetic Resonance Imaging of the Uterus. Invest Radiol, 2022. 57(6): p. 379-386.